BMC complementary medicine and therapies · 2020
Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taheri Yasaman, Suleria Hafiz Ansar Rasul, Martins Natália, Sytar Oksana, Beyatli Ahmet, Yeskaliyeva Balakyz, Seitimova Gulnaz, Salehi Bahare, Semwal Prabhakar, Painuli Sakshi, Kumar Anuj, Azzini Elena, Martorell Miquel, Setzer William N, Maroyi Alfred, Sharifi-Rad Javad
Аннотация
Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical activities on Alzheimer, Parkinson, and Huntington diseases, and even in amyotrophic lateral sclerosis. Also, myricetin has revealed other biological activities, among them as antidiabetic, anticancer, immunomodulatory, cardiovascular, analgesic and antihypertensive. However, few clinical trials have been performed using myricetin as nutraceutical. Thus, this review provides new insights on myricetin preclinical pharmacological activities, and role in selected clinical trials.